GILD vs KSCP · P/E 18, rev $7.80B vs rev $11.3M
Gilead Sciences Inc (GILD) versus Knightscope Inc (KSCP) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US. It is led by Daniel P. O'Day.
Knightscope Inc (KSCP) is a security & protection services company listed on NASDAQ.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported KSCP revenue for 2025-12-31 was $11.3M. Net income was -$33.8M. Revenue was up 4.9% from 2024-12-31 to 2025-12-31. KSCP currently screens at market cap $34.8M.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. KSCP currently screens at market cap $34.8M.
Not investment advice. Open the GILD and KSCP stock pages for the full models.
Not investment advice.